To our knowledge, this is the first report to demonstrate that the chemosensitizing effect of a selective MCL-1 inhibitor UMI-77 combined with cisplatin to treat ESCC cells. The gene discussed is MCL1; the disease is esophageal squamous cell carcinoma.